Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

Back

Autonomic Nervous System and Sickle Cell Disease

NCT04062409·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Assistance Publique - Hôpitaux de Paris

Heart rate variability during pulmonary function tests (spirometry, static volumes, DLCO/DLNO, exhaled NO at multiple flow rates) including salbutamol administration will be evaluated in patients with SCD (n=60) receiving asthma treatment or not, as compared to asthmatic children without SCD (n=30) matched for ethnicity

Age

6–16

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

age from 8 to 16 years (≥ 8 years and \< 16 years) (spirometry and DLCO study feasible)
Sub-Saharan African or Caribbean ethnic origin.
child with sickle cell disease referred for monitoring of respiratory function in the framework of its sickle cell disease and whether or not it presents a possible disease asthmatic (asthma treatment prescribed in the past year)
or asthmatic child (typical functional signs + history of exacerbation severe hospitalized or reversible obstructive pulmonary disorder) not sickle cell
addressed for respiratory function monitoring

You may not be if

Refusal to participate (lack of consent)
Sickle cell child of North African origin

The record

StatusCompleted

PhaseNo phase

Taking part90

StartedJan 2018

UpdatedFeb 3, 2023

Conditions

Heart Rate Variability (ANS Function)

Where1

Robert Debre Hospital
Paris, France

Clareo Health | Autonomic Nervous System and Sickle Cell Disease